Navigation Links
Global Bioinformatics Market 2013 - 2017
Date:1/13/2014

hysiomics and interactomics). Genomics contributes the highest to the bioinformatics market; it is poised to grow at a high CAGR from 2012 to 2017. The application of bioinformatics in genomics is driven by growing pharmacogenomics applications for the discovery of new drugs and characterization of older drugs, development of new bioinformatics tools to handle large sets of data generated through genomics research, and decreasing cost of DNA sequencing. Metabolomics is the fastest-growing application area due to developments in analytical instruments that enable profiling of metabolites with high throughput and accuracy.

North America accounted for the largest market share of the bioinformatics market, followed by Europe, in 2012. This is attributed by an increasing demand for bioinformatics in genomics and proteomics research, technological advancements, growing use of bioinformatics tools in the drug discovery process, and presence of a large number of market players. However, other regions such as Asian and Latin American countries represent emerging markets, owing to a rise in research outsourcing by pharmaceutical giants, increasing number of Contract Research Organizations (CROs), rise in public and private sector investment, and growing industry -academia partnerships.

Major players in the bioinformatics industry include Accelrys, Inc. (U.S.), Affymetrix, Inc. (U.S.), Life Technologies Corporation (U.S.), Illumina, Inc. (U.S.), and CLC bio. (Denmark). 


Key Topics Covered: 

1 Introduction

2 Executive Summary 

3 Market Overview 

4 Global Bioinformatics Market, By Sectors 

5 Global Bioinformatics Market, By Products & Services

6 Global Bioinformatics Market, By Applications 

7 Geographic Analysis

8 Competitive Landscape
'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. Loss of large carnivores poses global conservation problem
2. National Academy of Inventors 2013 Conference showcased global innovation
3. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
4. EcoHealth Alliance and Bat Conservation International forge partnership to work on global bat conservation and public health issues
5. Cloud mystery solved: Global temperatures to rise at least 4C by 2100
6. Cloud mystery solved: Global temperatures to rise at least 4°C by 2100
7. UNL research raises concerns about global crop projections
8. Telecoupling science shows Chinas forest sustainability packs global impact
9. Global Cancer Biomarkers Market 2012-2016 with Agilent Technologies Inc., Gen-Probe Inc. and Astellas Pharma US Inc. Dominating
10. Singapore joins global translational medicine network as Asia-Pacific hub
11. Scripps leads first global snapshot of key coral reef fishes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... 2, 2015 According to preliminary ... to somewhat higher than 125 MSEK. This exceeds the ... 2014 that revenues for Q1 2015 would be in ... for Q4 2014. The operating result for the first ... complete interim report will as previously communicated be published ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... NexID Biometrics LLC, whose spoof-mitigation technology boosts protection ... beginning of shipments of version 2.0 of its industry ... in Potsdam, N.Y. , is making ... here today at the Walter E. Washington Convention Center. ... boosts the accuracy rate range to 96.5 to 99.5 ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... release is available in German . ... that show a huge improvement in the light absorption ... This has been achieved by applying atomic layer coating. ... high sensitivity light response such as high efficiency solar ...
... in Earth,s climate from more than 100,000 years ago indicates ... previously thought and may be a good analog for future ... temperatures rise. The research findings also indicate that ... contributed more to sea-level rise at that time than melting ...
... The iconic salt marshes of the famous summer retreat ... the most popular recreational areas. The erosion is a ... Great Depression-era ditches constructed by Works Progress Administration (WPA) ... ecological cause and effect is described by Tyler Coverdale ...
Cached Biology News:Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 2Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 3Analysis of Greenland ice cores adds to historical record and provide glimpse into climate's future 4Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 2Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 3Depression-era drainage ditches emerge as sleeping threat to Cape Cod salt marshes 4
(Date:4/16/2015)... 16, 2015 OncoTAb, Inc., ... (UNC Charlotte) spin-out company, announced today the appointment ... M.D., as Chief Operating Officer (COO). Cooper brings ... in developing clinical diagnostic and biotechnology platforms in ... , Cooper’s extensive career transcends the field of ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
(Date:4/16/2015)... DIEGO , April 16, 2015  AnaptysBio, ... development of therapeutic antibodies, today announced the ... antibody program into IND-enabling studies. The Company,s ... novel treatment for generalized pustular psoriasis (GPP), ... unmet medical need. ANB019 is wholly owned within ...
(Date:4/16/2015)... Switzerland , April 16, ... part of Debiopharm Group ™ , a Swiss-based ... target unmet medical needs as well as ... on the investigational compounds Debio 1143 (SMAC mimetic) ... presented at the 2015 Annual meeting of ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
... CARLOS, Calif., Dec. 2 SleepQuest is proud to ... Joint Commission on the,Accreditation of Health Care Organizations (JCAHO) ... and safety. , ... of,national standards by The Joint Commission,s home care service ...
... Martek Biosciences Corporation (Nasdaq: MATK ) announced that it ... year 2008 on December 11, 2008, at approximately 4:00 p.m. Eastern ... will conduct a conference call to discuss these results with investors. ... webcast by visiting Martek,s web site at http://investors.martek.com . , ...
... On Track to File NDA with FDA in Early ... WOODCLIFF LAKE, N.J., Dec. 2 Strativa Pharmaceuticals, the ... PRX ) today announced that its development ... pivotal bioequivalence studies for a thin film formulation of ...
Cached Biology Technology:SleepQuest Achieves Coveted Accreditation 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 2Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 3Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film 4
... The Jouan RC Maxi MB (for ... of vacuum concentrator/centrifugal evaporator systems respond to ... for rapid and safe concentration of heat-labile ... with pumps, different of cold traps and ...
... Jouan RC10 series of vacuum concentrators/centrifugal evaporators ... features allied to rapid and safe concentration ... be combined with oil-free or high vacuum ... a wide selection of rotors (eliminating sample ...
... RC Standard MB (For small quantities of ... samples) of vacuum concentrator/centrifugal evaporator systems respond ... biochemistry for rapid and safe concentration of ... expanded with pumps, different of cold traps ...
The PxE Thermal Cycler (PxE) is a licensed 96 well PCR machine, developed to provide all fundamental features for value for money thermal cycling....
Biology Products: